fenoldopam has been researched along with Critical Illness in 11 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension." | 9.19 | Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. ( Alvaro, G; Amantea, B; Baldassarri, R; Bellomo, R; Bove, T; Calabrò, MG; Camata, A; Caramelli, F; Cariello, C; Comis, M; Conte, M; Dal Checco, E; Faita, L; Frontini, M; Galdieri, N; Guarracino, F; Landoni, G; Lembo, R; Maglioni, E; Martinez, B; Pala, G; Pappalardo, F; Pasero, DC; Paternoster, G; Persi, B; Pinelli, F; Pisano, A; Renzini, M; Saleh, O; Scandroglio, AM; Verdecchia, C; Zangrillo, A; Zucchetti, MC, 2014) |
| "Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension." | 5.19 | Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. ( Alvaro, G; Amantea, B; Baldassarri, R; Bellomo, R; Bove, T; Calabrò, MG; Camata, A; Caramelli, F; Cariello, C; Comis, M; Conte, M; Dal Checco, E; Faita, L; Frontini, M; Galdieri, N; Guarracino, F; Landoni, G; Lembo, R; Maglioni, E; Martinez, B; Pala, G; Pappalardo, F; Pasero, DC; Paternoster, G; Persi, B; Pinelli, F; Pisano, A; Renzini, M; Saleh, O; Scandroglio, AM; Verdecchia, C; Zangrillo, A; Zucchetti, MC, 2014) |
| " Two unblinded reviewers selected randomized controlled trials that used fenoldopam in the prevention or treatment of acute kidney injury in postoperative or intensive care patients." | 4.84 | Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. ( Biondi-Zoccai, GG; Bove, T; Calabrò, MG; De Luca, M; Landoni, G; Ranucci, M; Tumlin, JA; Zangrillo, A, 2007) |
| "Acute kidney injury is a frequent problem among many critically ill patients, commonly in the context of multiple organ failure and decreased renal perfusion." | 2.76 | Fenoldopam in critically ill patients with early renal dysfunction. A crossover study. ( Barquist, E; Cobas, M; Cudemus, G; De La Pena, M; Paparcuri, G; Varon, A, 2011) |
| "Fenoldopam mesylate is a selective dopamine-1 agonist, with no effect on dopamine-2 and alpha1 receptors, producing a selective renal vasodilation." | 2.72 | A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. ( Ancona, G; Bortone, D; Brienza, N; Bruno, F; Dalfino, L; Faconda, G; Fiore, T; Guagliardi, C; Malcangi, V; Ribezzi, M; Trerotoli, P, 2006) |
| "Fenoldopam was administered at different doses (0." | 2.71 | Monitoring renal oxygen supply in critically-ill patients using urinary oxygen tension. ( Alberto De Blasi, R; Coluzzi, F; Conti, G; Morelli, A; Orecchioni, A; Pietropaoli, P; Rocco, M, 2003) |
| "D." | 1.33 | Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent. ( Finkel, K; Gubert, M; Johnson, T; Samuels, J; Shaw, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bove, T | 2 |
| Zangrillo, A | 2 |
| Guarracino, F | 1 |
| Alvaro, G | 1 |
| Persi, B | 1 |
| Maglioni, E | 1 |
| Galdieri, N | 1 |
| Comis, M | 1 |
| Caramelli, F | 1 |
| Pasero, DC | 1 |
| Pala, G | 1 |
| Renzini, M | 1 |
| Conte, M | 1 |
| Paternoster, G | 1 |
| Martinez, B | 1 |
| Pinelli, F | 1 |
| Frontini, M | 1 |
| Zucchetti, MC | 1 |
| Pappalardo, F | 1 |
| Amantea, B | 1 |
| Camata, A | 1 |
| Pisano, A | 1 |
| Verdecchia, C | 1 |
| Dal Checco, E | 1 |
| Cariello, C | 1 |
| Faita, L | 1 |
| Baldassarri, R | 1 |
| Scandroglio, AM | 1 |
| Saleh, O | 1 |
| Lembo, R | 1 |
| Calabrò, MG | 2 |
| Bellomo, R | 1 |
| Landoni, G | 2 |
| Cobas, M | 1 |
| Paparcuri, G | 1 |
| De La Pena, M | 1 |
| Cudemus, G | 1 |
| Barquist, E | 1 |
| Varon, A | 1 |
| Mathur, VS | 1 |
| Morelli, A | 1 |
| Rocco, M | 1 |
| Conti, G | 1 |
| Orecchioni, A | 1 |
| Alberto De Blasi, R | 1 |
| Coluzzi, F | 1 |
| Pietropaoli, P | 1 |
| Samuels, J | 1 |
| Finkel, K | 1 |
| Gubert, M | 1 |
| Johnson, T | 1 |
| Shaw, A | 1 |
| Brienza, N | 1 |
| Malcangi, V | 1 |
| Dalfino, L | 1 |
| Trerotoli, P | 1 |
| Guagliardi, C | 1 |
| Bortone, D | 1 |
| Faconda, G | 1 |
| Ribezzi, M | 1 |
| Ancona, G | 1 |
| Bruno, F | 1 |
| Fiore, T | 1 |
| Murray, PT | 1 |
| Ricci, Z | 1 |
| Ronco, C | 1 |
| Biondi-Zoccai, GG | 1 |
| Tumlin, JA | 1 |
| De Luca, M | 1 |
| Ranucci, M | 1 |
| Moffett, BS | 1 |
| Mott, AR | 1 |
| Nelson, DP | 1 |
| Goldstein, SL | 1 |
| Jefferies, JL | 1 |
| Aurora, RN | 1 |
| Milite, F | 1 |
| Carlon, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Fenoldopam in Reducing the Need for Renal Replacement Therapy After Cardiac Surgery. A Randomized Controlled Study.[NCT00621790] | Phase 3 | 667 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for fenoldopam and Critical Illness
| Article | Year |
|---|---|
The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant, and hypertensive patients.
Topics: Critical Illness; Dopamine Agonists; Fenoldopam; Humans; Hypertension; Kidney Diseases; Liver Transp | 2003 |
Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.
Topics: Acute Kidney Injury; Critical Illness; Fenoldopam; Humans; Randomized Controlled Trials as Topic; Ri | 2007 |
5 trials available for fenoldopam and Critical Illness
| Article | Year |
|---|---|
Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Creatinine; Critical Illness; Double-Blind M | 2014 |
Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Cross-Over Studies; Dopamine Agonists; Double-Bl | 2011 |
Monitoring renal oxygen supply in critically-ill patients using urinary oxygen tension.
Topics: Adolescent; Blood Urea Nitrogen; Child; Creatinine; Critical Illness; Diuresis; Dopamine Agonists; E | 2003 |
A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
Topics: Acute Kidney Injury; Aged; Critical Illness; Dopamine; Dopamine Agonists; Female; Fenoldopam; Humans | 2006 |
'Renal-dose' fenoldopam for early-stage renal dysfunction in critically ill patients.
Topics: Adult; Critical Illness; Dopamine Agonists; Fenoldopam; Humans; Kidney Diseases; Prospective Studies | 2006 |
4 other studies available for fenoldopam and Critical Illness
| Article | Year |
|---|---|
Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Dopamine Agonists; Dose-Response Relationship, D | 2005 |
Fenoldopam: renal-dose dopamine redux?
Topics: Acute Kidney Injury; Critical Illness; Dopamine; Dopamine Agonists; Fenoldopam; Humans; Infusions, I | 2006 |
Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review.
Topics: Adolescent; Adult; Child; Child, Preschool; Creatinine; Critical Illness; Diuresis; Dopamine Agonist | 2008 |
Preventing renal failure in critically ill patients.
Topics: Acute Kidney Injury; Critical Illness; Dopamine Agonists; Fenoldopam; Humans; Renal Circulation | 1999 |